Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 2/20 | 0.65 |
| ▸ | ACACA | Q13085 | 2/20 | 0.65 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.61 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.52 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | HMGCR | P04035 | 2/20 | 0.40 |
| ▸ | CRYAB | P02511 | 3/20 | 0.40 |
| ▸ | CRYAA | P02489 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | EBP | Q15125 | 3/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3479594 | 1.00 | ACLY (0.65) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cyclolaudenol (24S) SCHEMBL679913 | 0.87 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cyclolaudenol (24S) SCHEMBL3191608 | 0.87 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL12152356 | 0.87 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL1881616 | 0.87 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL1881613 | 0.87 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL13324286 | 0.87 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL13801860 | 0.87 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL455049 | 0.87 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL455050 | 0.87 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200093135-A1 | SYSTEMS FOR PEST ELIMINATION, SUPPRESSION OR CONTROL | EMEKATECH LLC (US) | 2020-03-26 | — | — | US | claimed |
| US-20170055532-A1 | SYSTEMS FOR PEST ELIMINATION, SUPPRESSION OR CONTROL | Emekatech, LLC. (US) | 2017-03-02 | — | — | US | claimed |
| EP-3110253-A1 | SYSTEMS FOR PEST ELIMINATION, SUPPRESSION OR CONTROL | Emekatech, LLC (US) | 2017-01-04 | — | — | EP | claimed |
| WO-2015127311-A1 | SYSTEMS FOR PEST ELIMINATION, SUPPRESSION OR CONTROL | EMEKATECH, LLC (US) | 2015-08-27 | — | — | WO | claimed |
| US-20200093135-A1 | SYSTEMS FOR PEST ELIMINATION, SUPPRESSION OR CONTROL | EMEKATECH LLC (US) | 2020-03-26 | — | — | US | disclosed |
| US-20170055532-A1 | SYSTEMS FOR PEST ELIMINATION, SUPPRESSION OR CONTROL | Emekatech, LLC. (US) | 2017-03-02 | — | — | US | disclosed |
| EP-3110253-A1 | SYSTEMS FOR PEST ELIMINATION, SUPPRESSION OR CONTROL | Emekatech, LLC (US) | 2017-01-04 | — | — | EP | disclosed |
| WO-2015127311-A1 | SYSTEMS FOR PEST ELIMINATION, SUPPRESSION OR CONTROL | EMEKATECH, LLC (US) | 2015-08-27 | — | — | WO | disclosed |
| EP-1795200-B1 | MEDICINE AND FOOD/BEVERAGE FOR AMELIORATING HYPERGLYCEMIA | MORINAGA MILK INDUSTRY CO LTD (JP) | 2014-04-23 | — | — | EP | disclosed |
| US-7674784-B2 | Drug and food or drink for improving hyperglycemia | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2010-03-09 | — | — | US | disclosed |
| US-20070196435-A1 | Drug and food or drink for improving hyperglycemia | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2007-08-23 | — | — | US | disclosed |
| EP-1795200-A1 | MEDICINE AND FOOD/BEVERAGE FOR AMELIORATING HYPERGLYCEMIA | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2007-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196435-A1 | Drug and food or drink for improving hyperglycemia | GPR119, SLC2A9, GCKR | ACLY 565/4885ACACA 305/4885PTPN11 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.